NAD+ has become one of the most discussed molecules in longevity and metabolic medicine — and one of the most marketed. The science behind it is genuinely interesting. The marketing around it is frequently overstated. This article separates the two.
Below is a clinical guide to what NAD+ actually is, why levels decline with age, what the published research supports, and how injectable NAD+ therapy fits into a physician-supervised metabolic protocol.
What NAD+ Actually Does in the Body
NAD+ — nicotinamide adenine dinucleotide — is a coenzyme present in every living cell. It is not a vitamin you can directly supplement easily, and it is not a peptide. It is a small molecule that functions as a critical electron carrier and substrate in three domains of cellular biology that matter clinically:
- Mitochondrial energy production. NAD+ is required in the electron transport chain to generate ATP — the cell's energy currency. Lower NAD+ means less efficient ATP production.
- DNA repair. PARP (poly ADP-ribose polymerase) enzymes — which detect and repair DNA damage — consume NAD+ as their substrate. Adequate NAD+ supports the cellular machinery that maintains genomic integrity.
- Sirtuin activation. Sirtuins are a class of proteins involved in cellular stress response, metabolic regulation, and longevity-related signaling. Sirtuin activity is NAD+-dependent.
Why NAD+ Levels Decline With Age
Multiple published reviews — including work from the Sinclair lab at Harvard — document a substantial decline in tissue NAD+ levels with age. By age 60, NAD+ levels in many tissues are typically 40–60% lower than they were at age 30. The decline is multifactorial: increased consumption by enzymes such as CD38, reduced de novo synthesis, oxidative stress, and chronic low-grade inflammation all contribute.
The clinical relevance: many of the changes patients describe as "feeling old" — persistent fatigue, slower recovery, reduced metabolic flexibility, declining cognitive sharpness — overlap with the cellular consequences of NAD+ decline. NAD+ is not the only factor, and it is not a fountain of youth. But it is one of the biological changes that shifts with age in a way that may be modifiable.
What the Research Supports
The Rajman, Chwalek, and Sinclair 2018 review in Cell Metabolism ("Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence") summarized the preclinical evidence base across multiple NAD+ precursors and boosters. Findings reported across animal studies include:
- Improved insulin sensitivity and metabolic markers
- Improved liver regeneration after hepatectomy
- Kidney protection in models of acute kidney injury
- Cardiac protection in ischemia-reperfusion models
- Improvements in cognitive and metabolic markers in aging models
Human evidence is more limited and indication-specific. Outcomes should be framed as supported, not guaranteed. NAD+ therapy is a tool with a genuine biological rationale — not a guaranteed intervention with a defined response curve.
Injectable NAD+ vs. IV NAD+ vs. Oral Precursors
Several different forms of NAD+ supplementation are commercially available. They are not equivalent.
- Oral NAD+ precursors (NMN, NR). Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) are precursor molecules that must be converted by the body into NAD+. Bioavailability is variable and absorption is less efficient than direct administration.
- Injectable subcutaneous NAD+. Direct administration of the NAD+ molecule via a small subcutaneous injection. Bypasses first-pass metabolism, allows steady absorption, and is self-administered at home. This is the form Vitality offers as a peptide protocol.
- IV NAD+. The same molecule delivered intravenously at a clinic. Achieves higher peak concentrations more rapidly. This is the form delivered through our IV therapy program — see IV NAD+ therapy for the comparison in detail.
The choice between subcutaneous and IV NAD+ depends on patient goals, schedule, sensitivity to infusion, and physician judgment. Both deliver the same molecule with different pharmacokinetics.
Who Benefits Most
Patients commonly considered for injectable NAD+ therapy include:
- Adults experiencing age-related fatigue, slower recovery, or reduced cognitive sharpness
- Patients pursuing longevity-focused metabolic optimization
- Patients on TRT or GLP-1 protocols who want to support cellular energy alongside hormone optimization
- Patients recovering from periods of high physiologic stress
NAD+ is not appropriate for everyone. Patients with certain medical conditions, on specific medications, or with contraindications identified during evaluation may not be candidates. Dr. Jaqua reviews complete labs and history before prescribing any protocol.
Regulatory Status
NAD+ has remained continuously available through licensed 503A compounding pharmacies with a valid physician prescription. It was not subject to the 2024 peptide compounding restrictions that affected peptides like BPC-157 and TB-500. NAD+ is used off-label and has not received drug approval from the FDA. At Vitality Texas, all NAD+ is sourced from licensed compounding pharmacies and prescribed by Dr. Jaqua following lab evaluation.
What a Vitality NAD+ Protocol Looks Like
Every NAD+ protocol at Vitality begins with a physician evaluation and appropriate labs — including a comprehensive metabolic panel, hormone markers, and any other testing relevant to your history. Dr. Jaqua reviews the labs, discusses your goals, and determines whether NAD+ is the appropriate therapy and which delivery method fits your situation.
If injectable NAD+ is appropriate, you receive a prescription from a licensed compounding pharmacy along with self-injection training. Frequency and dose are individualized. NAD+ is commonly combined with TRT, GLP-1 medical weight loss, or growth hormone peptide protocols — all coordinated under one physician.
The Bottom Line
NAD+ is one of the more biologically grounded interventions in the longevity and metabolic optimization space. The science is real. The marketing is loud. The right approach is somewhere in between: a physician evaluation, an honest conversation about what the evidence supports and what it doesn't, and a protocol designed around your labs and your goals.
Schedule a peptide therapy consultation at Vitality →
Frequently Asked Questions
What is NAD+ and why does it matter?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell in your body. It is essential for mitochondrial production of ATP (the cell's energy currency), for DNA repair via PARP enzymes, and for activating sirtuins — proteins involved in cellular stress response and longevity pathways. Research documents that NAD+ levels decline meaningfully with age, which is associated with reduced cellular energy and metabolic function.
Was NAD+ affected by the FDA peptide restrictions?
No. NAD+ was never on the FDA's Category 2 restricted bulk drug substance list. It has remained continuously available through licensed 503A compounding pharmacies with a valid physician prescription. NAD+ does not require reclassification — it has been Category 1 throughout.
What's the difference between injectable NAD+ and IV NAD+?
Both contain the same NAD+ molecule. The difference is the delivery method. Injectable subcutaneous NAD+ is self-administered with a small needle — convenient, lower cost per session, and absorbed gradually. IV NAD+ is administered as an infusion at our clinic and delivers NAD+ directly into the bloodstream, producing higher peak concentrations. Choice of delivery method is part of the protocol decision Dr. Jaqua makes with each patient.
What can patients realistically expect?
Patients on injectable NAD+ protocols commonly report improvements in energy and mental clarity within 2–4 weeks. Effects on metabolic health, body composition, and recovery generally develop over longer periods. Outcomes are supported, not guaranteed — individual results vary based on baseline NAD+ status, age, lifestyle, and adherence.
Can NAD+ be combined with TRT or GLP-1 weight loss?
Yes. NAD+ is commonly stacked with testosterone replacement therapy and GLP-1 medications as part of a comprehensive metabolic and longevity protocol. Dr. Jaqua coordinates the full program, ensuring all components are appropriate for your labs, medical history, and goals.